BMJ9h
AB0285 EFFECTIVENESS OF IMMUNOSUPPRESSIVE THERAPY FOR CONNECTIVE TISSUE DISEASE–ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
1 Graduate School of Medicine, The University of Tokyo, Department of Cardiovascular Medicine, Tokyo, Japan 2 Graduate School of Medicine, The University of Tokyo., Department of Therapeutic Strategy ...
BMJ17h
Guidelines for musculoskeletal ultrasound in rheumatology
Dr B Manger, Department of Internal Medicine III, University Erlangen Krankenhausstr 12, D-91054 Erlangen, Germany Newer US techniques, which are currently being evaluated, include colour and power ...
BMJ1d
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
1 Division of Clinical Immunology and Rheumatology, Academic Medical Centre/University of Amsterdam, The Netherlands 2 Department of Clinical Epidemiology and Biostatistics, Academic Medical ...
BMJ2d
Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
Objectives To identify factors that predict response to belimumab treatment in the phase 3 BLISS trials of autoantibody-positive systemic lupus erythematosus (SLE) and further analyse clinical ...
BMJ2d
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
Background Upadacitinib is a Janus kinase inhibitor under evaluation for the treatment of psoriatic arthritis (PsA). We evaluated upadacitinib in patients with PsA and prior inadequate response or ...
BMJ2d
Efficacy of prednisone 1–4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial
Objective: A randomised double-blind placebo controlled withdrawal clinical trial of prednisone versus placebo in patients with rheumatoid arthritis (RA), treated in usual clinical care with 1–4 ...
BMJ3d
Settings and artefacts relevant in colour/power Doppler ultrasound in rheumatology
The Parker Institute, Frederiksberg Hospital, Copenhagen University Hospital, The Capital Region of Denmark, DK-2000 Copenhagen F, Denmark Søren Torp-Pedersen, The Parker Institute, Frederiksberg ...
BMJ3d
Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus
Correspondence to Dr Keishi Fujio, Department of Allergy and Rheumatology, The University of Tokyo, Bunkyo-ku, Tokyo, Japan; fujiok-int{at}h.u-tokyo.ac.jp; Dr Yukiko Iwasaki, Department of Palliative ...
BMJ3d
Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort
Correspondence to Dr Laura C Coates, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Botnar Research CentreWindmill Road, Oxford, OX3 7LD, UK; ...
BMJ3d
Longitudinal validation of periarticular bone area and 3D shape as biomarkers for knee OA progression? Data from the FNIH OA Biomarkers Consortium
Objective To perform a longitudinal validation study of imaging bone biomarkers of knee osteoarthritis (OA) progression. Methods We undertook a nested case–control study within the Osteoarthritis ...
BMJ3d
Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation
1 Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands Objectives Millions of patients worldwide are treated with therapeutic ...
BMJ4d
Relationship between serum urate concentration and clinically evident incident gout: an individual participant data analysis
Correspondence to Prof Nicola Dalbeth, Department of Medicine, Faculty of Medical and Health Sciences, University of Auckland, Auckland 1, New Zealand; n.dalbeth{at}auckland.ac.nz Objectives To ...